The present invention provides pharmaceutical uses of betaines, and especially glycine betaine, such as for the treatment of thromboses not induced by hyperhomocystenemia or homocystinuria, of blood disorders, such as blood coagulation and thrombi formation.

 
Web www.patentalert.com

< Calcitonin drug-oligomer conjugates, and uses thereof

> Pharmaceutical compositions comprising cross-linked small molecule amine polymers

> Hydrolytically degradable polymers and hydrogels made therefrom
~ 00554